Home
Live Updates
T-Cell Exhaustion in CLL: Allogeneic CAR T Trial Reaching Patients With Unmet Need : comparemela.com
T-Cell Exhaustion in CLL: Allogeneic CAR T Trial Reaching Patients With Unmet Need
"Off the shelf" CAR T-cell therapies could offer a solution in chronic lymphocytic leukemia, where T-cell exhaustion creates treatment challenges. This article will appear in the May 2024 issue of Evidence-Based Oncology.
Related Keywords
Florida ,
United States ,
Tampa ,
Frederickl Locke ,
Bristol Myers Squibb Breyanzi ,
Javier Pinilla Ibarz ,
David Chang ,
Department Of Malignant Hematology ,
Bristol Myers Squibb ,
Moffitt Cancer Center Lymphoma Section ,
Cell Therapy Initiative ,
Novartis ,
Moffitt Cancer Center ,
Lymphoma Section ,
Malignant Hematology ,
Allogene Therapeutics ,
Current Oncology ,
Cell Exhaustion ,
Cell Therapy ,
Address Unmet ,
Bristol Myers Squib ,
Moffitt Cancer ,
Immune Cell Therapy Initiative ,
Allogene President ,
Updated April ,
comparemela.com © 2020. All Rights Reserved.